FDA 483 - Kwabena (NMI) Ayesu, M.D. - January 27, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Kwabena (NMI) Ayesu, M.D., a clinical investigator in Orlando, FL, was cited for significant deviations from investigational plans and regulatory requirements. The inspection revealed failures in calculating absolute glomerular filtration rates (aGFR) for study subjects, leading to the enrollment of ineligible participants. Additionally, the firm failed to promptly report unanticipated problems involving risk to human subjects to the Institutional Review Board (IRB).
ID · 5cdbdc19-b40e-466b-9d16-feb8f6dc5159